Literature DB >> 33170070

Incorporating Latent Variables Using Nonnegative Matrix Factorization Improves Risk Stratification in Brugada Syndrome.

Gary Tse1,2, Jiandong Zhou3, Sharen Lee4, Tong Liu1, George Bazoukis5, Panagiotis Mililis5, Ian C K Wong6,7, Cheng Chen2, Yunlong Xia2, Tsukasa Kamakura8, Takeshi Aiba8, Kengo Kusano8, Qingpeng Zhang3, Konstantinos P Letsas5.   

Abstract

Background A combination of clinical and electrocardiographic risk factors is used for risk stratification in Brugada syndrome. In this study, we tested the hypothesis that the incorporation of latent variables between variables using nonnegative matrix factorization can improve risk stratification compared with logistic regression. Methods and Results This was a retrospective cohort study of patients presented with Brugada electrocardiographic patterns between 2000 and 2016 from Hong Kong, China. The primary outcome was spontaneous ventricular tachycardia/ventricular fibrillation. The external validation cohort included patients from 3 countries. A total of 149 patients with Brugada syndrome (84% males, median age of presentation 50 [38-61] years) were included. Compared with the nonarrhythmic group (n=117, 79%), the spontaneous ventricular tachycardia/ ventricular fibrillation group (n=32, 21%) were more likely to suffer from syncope (69% versus 37%, P=0.001) and atrial fibrillation (16% versus 4%, P=0.023) as well as displayed longer QTc intervals (424 [399-449] versus 408 [386-425]; P=0.020). No difference in QRS interval was observed (108 [98-114] versus 102 [95-110], P=0.104). Logistic regression found that syncope (odds ratio, 3.79; 95% CI, 1.64-8.74; P=0.002), atrial fibrillation (odds ratio, 4.15; 95% CI, 1.12-15.36; P=0.033), QRS duration (odds ratio, 1.03; 95% CI, 1.002-1.06; P=0.037) and QTc interval (odds ratio, 1.02; 95% CI, 1.01-1.03; P=0.009) were significant predictors of spontaneous ventricular tachycardia/ventricular fibrillation. Increasing the number of latent variables of these electrocardiographic indices incorporated from n=0 (logistic regression) to n=6 by nonnegative matrix factorization improved the area under the curve of the receiving operating characteristics curve from 0.71 to 0.80. The model improves area under the curve of external validation cohort (n=227) from 0.64 to 0.71. Conclusions Nonnegative matrix factorization improves the predictive performance of arrhythmic outcomes by extracting latent features between different variables.

Entities:  

Keywords:  Brugada syndrome; ECG; depolarization; latent variable; nonnegative matrix factorization; repolarization; risk stratification

Mesh:

Year:  2020        PMID: 33170070      PMCID: PMC7763720          DOI: 10.1161/JAHA.119.012714

Source DB:  PubMed          Journal:  J Am Heart Assoc        ISSN: 2047-9980            Impact factor:   5.501


  31 in total

1.  Incidence and predictors of atrial fibrillation in a Chinese cohort of Brugada syndrome.

Authors:  Gary Tse; Sharen Lee; Ngai Shing Mok; Tong Liu; Dong Chang
Journal:  Int J Cardiol       Date:  2020-05-07       Impact factor: 4.164

2.  Temporal Variability in Electrocardiographic Indices in Subjects With Brugada Patterns.

Authors:  Sharen Lee; Jiandong Zhou; Tong Liu; Konstantinos P Letsas; Sandeep S Hothi; Vassilios S Vassiliou; Guoliang Li; Adrian Baranchuk; Raymond W Sy; Dong Chang; Qingpeng Zhang; Gary Tse
Journal:  Front Physiol       Date:  2020-09-03       Impact factor: 4.566

3.  Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation.

Authors:  Hiro Kawata; Hiroshi Morita; Yuko Yamada; Takashi Noda; Kazuhiro Satomi; Takeshi Aiba; Mitsuaki Isobe; Satoshi Nagase; Kazufumi Nakamura; Kengo Fukushima Kusano; Hiroshi Ito; Shiro Kamakura; Wataru Shimizu
Journal:  Heart Rhythm       Date:  2013-04-12       Impact factor: 6.343

4.  Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes.

Authors:  Louise R A Olde Nordkamp; Arja S Vink; Arthur A M Wilde; Freek J de Lange; Jonas S S G de Jong; Wouter Wieling; Nynke van Dijk; Hanno L Tan
Journal:  Heart Rhythm       Date:  2014-10-13       Impact factor: 6.343

5.  Repolarization abnormalities unmasked with exercise in sudden cardiac death survivors with structurally normal hearts.

Authors:  Kevin M W Leong; Fu Siong Ng; Caroline Roney; Christopher Cantwell; Matthew J Shun-Shin; Nicholas W F Linton; Zachary I Whinnett; David C Lefroy; D Wyn Davies; Sian E Harding; Phang Boon Lim; Darrel Francis; Nicholas S Peters; Amanda M Varnava; Prapa Kanagaratnam
Journal:  J Cardiovasc Electrophysiol       Date:  2017-12-07

6.  Normal interventricular differences in tissue architecture underlie right ventricular susceptibility to conduction abnormalities in a mouse model of Brugada syndrome.

Authors:  Allen Kelly; Simona Salerno; Adam Connolly; Martin Bishop; Flavien Charpentier; Tomas Stølen; Godfrey L Smith
Journal:  Cardiovasc Res       Date:  2018-04-01       Impact factor: 10.787

7.  A score model to predict risk of events in patients with Brugada Syndrome.

Authors:  Juan Sieira; Giulio Conte; Giuseppe Ciconte; Gian-Battista Chierchia; Ruben Casado-Arroyo; Giannis Baltogiannis; Giacomo Di Giovanni; Yukio Saitoh; Justo Juliá; Giacomo Mugnai; Mark La Meir; Francis Wellens; Jens Czapla; Gudrun Pappaert; Carlo de Asmundis; Pedro Brugada
Journal:  Eur Heart J       Date:  2017-06-07       Impact factor: 29.983

8.  A novel surface electrocardiogram-based marker of ventricular arrhythmia risk in patients with ischemic cardiomyopathy.

Authors:  William B Nicolson; Gerry P McCann; Peter D Brown; Alastair J Sandilands; Peter J Stafford; Fernando S Schlindwein; Nilesh J Samani; G André Ng
Journal:  J Am Heart Assoc       Date:  2012-08-24       Impact factor: 5.501

9.  Higher Dispersion Measures of Conduction and Repolarization in Type 1 Compared to Non-type 1 Brugada Syndrome Patients: An Electrocardiographic Study From a Single Center.

Authors:  Gary Tse; Ka Hou Christien Li; Guangping Li; Tong Liu; George Bazoukis; Wing Tak Wong; Matthew T V Chan; Martin C S Wong; Yunlong Xia; Konstantinos P Letsas; Gary Chin Pang Chan; Yat Sun Chan; William K K Wu
Journal:  Front Cardiovasc Med       Date:  2018-10-04

10.  Outcomes in Brugada Syndrome Patients With Implantable Cardioverter-Defibrillators: Insights From the SGLT2 Registry.

Authors:  Sharen Lee; Ka Hou Christien Li; Jiandong Zhou; Keith Sai Kit Leung; Rachel Wing Chuen Lai; Guoliang Li; Tong Liu; Konstantinos P Letsas; Ngai Shing Mok; Qingpeng Zhang; Gary Tse
Journal:  Front Physiol       Date:  2020-03-10       Impact factor: 4.566

View more
  6 in total

1.  Territory-wide cohort study of Brugada syndrome in Hong Kong: predictors of long-term outcomes using random survival forests and non-negative matrix factorisation.

Authors:  Sharen Lee; Jiandong Zhou; Ka Hou Christien Li; Keith Sai Kit Leung; Ishan Lakhani; Tong Liu; Ian Chi Kei Wong; Ngai Shing Mok; Chloe Mak; Kamalan Jeevaratnam; Qingpeng Zhang; Gary Tse
Journal:  Open Heart       Date:  2021-02

Review 2.  Pathogenesis and Management of Brugada Syndrome: Recent Advances and Protocol for Umbrella Reviews of Meta-Analyses in Major Arrhythmic Events Risk Stratification.

Authors:  Hasina Masha Aziz; Michał P Zarzecki; Sebastian Garcia-Zamora; Min Seo Kim; Piotr Bijak; Gary Tse; Hong-Hee Won; Paweł T Matusik
Journal:  J Clin Med       Date:  2022-03-30       Impact factor: 4.241

Review 3.  Clinical Characteristics, Genetic Findings and Arrhythmic Outcomes of Patients with Catecholaminergic Polymorphic Ventricular Tachycardia from China: A Systematic Review.

Authors:  Justin Leung; Sharen Lee; Jiandong Zhou; Kamalan Jeevaratnam; Ishan Lakhani; Danny Radford; Emma Coakley-Youngs; Levent Pay; Göksel Çinier; Meltem Altinsoy; Amir Hossein Behnoush; Elham Mahmoudi; Paweł T Matusik; George Bazoukis; Sebastian Garcia-Zamora; Shaoying Zeng; Ziliang Chen; Yunlong Xia; Tong Liu; Gary Tse
Journal:  Life (Basel)       Date:  2022-07-22

4.  Multi-omics assessment of dilated cardiomyopathy using non-negative matrix factorization.

Authors:  Rewati Tappu; Jan Haas; David H Lehmann; Farbod Sedaghat-Hamedani; Elham Kayvanpour; Andreas Keller; Hugo A Katus; Norbert Frey; Benjamin Meder
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

5.  Ventricular Tachyarrhythmia Risk in Paediatric/Young vs. Adult Brugada Syndrome Patients: A Territory-Wide Study.

Authors:  Sharen Lee; Wing Tak Wong; Ian Chi Kei Wong; Chloe Mak; Ngai Shing Mok; Tong Liu; Gary Tse
Journal:  Front Cardiovasc Med       Date:  2021-06-11

6.  Incorporating Latent Variables Using Nonnegative Matrix Factorization Improves Risk Stratification in Brugada Syndrome.

Authors:  Gary Tse; Jiandong Zhou; Sharen Lee; Tong Liu; George Bazoukis; Panagiotis Mililis; Ian C K Wong; Cheng Chen; Yunlong Xia; Tsukasa Kamakura; Takeshi Aiba; Kengo Kusano; Qingpeng Zhang; Konstantinos P Letsas
Journal:  J Am Heart Assoc       Date:  2020-11-10       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.